Christian Bjerregård Øland

Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)*

Jan Gutermuth, Andrew Pink, Margitta Worm et al. · British Journal of Dermatology · 2021 · 89 citations · Full text

Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar

M. Berendsen, Christian Bjerregård Øland, Pauli Bles et al. · Journal of the Pediatric Infectious Diseases Society · 2019 · 78 citations

Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial

Frederik Schaltz‐Buchholzer, Morten Bjerregaard-Andersen, Christian Bjerregård Øland et al. · Clinical Infectious Diseases · 2019 · 44 citations · Full text

Understanding the child mortality decline in Guinea-Bissau: the role of population-level nutritional status measured by mid-upper arm circumference

Andreas Rieckmann, Ane Bærent Fisker, Christian Bjerregård Øland et al. · International Journal of Epidemiology · 2022 · 16 citations

Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years

Raj Chovatiya, Simone Ribero, Andreas Wollenberg et al. · American Journal of Clinical Dermatology · 2025 · 13 citations · Full text